• 한국작물학회지
• /
• 제67권4호
• /
• pp.211-221
• /
• 2022

논 토양 조건에서 팥의 생육기 중 초기 생육 단계에 해당되는 유묘기에 과습 스트레스 처리 후 생육특성 변화 및 팥잎의 단백질 발현 양상을 조사한 결과는 다음과 같다. 1. 아라리(밀양 8호)를 공시 품종으로 과습 스트레스 실험을 진행하였다. 3일간 과습 처리하는 동안 팥의 초장과 생체중(잎, 줄기)은 통계적으로 유의하지는 않았으나 생체중(뿌리)와 SPAD value 값은 통계적으로 유의한 결과가 나왔다. 2. 과습 처리 3일 후 잎의 단백질 발현 양상을 확인한 결과 21개의 차별 발현된 단백질 중 과습 스트레스 처리에 의해 9개의 단백질들이 up-regulated 되었고, 12개의 단백질들이 down-regulated 되었다. 단백질을 기능별로 분류한 결과 Biological Process에서 carbohydrate metabolic process와 관련된 단백질들이 가장 많이 나왔고 Cellular Component에서는 Chloroplast에서 가장 많이 존재하였다. 3. Regulatory protein과 관련된 Maturase K 단백질은 처리구에서 대조구보다 발현양이 증가한 것으로 나타났다. 4. Carbohydrate metabolic process와 관련된 Malate dehydrogenase 단백질과 Glyceraldehyde-3-phosphate dehydrogenase 단백질은 과습 스트레스를 받았을 경우 단백질 발현양이 증가하였다. 5. Photosynthesis와 관련된 Carbonic anhydrase (CA)는 처리구보다 대조구에서 단백질 발현량이 더 증가한 것을 확인할 수 있었다. 스트레스와 관련된 단백질 Superoxide dismutase는 처리구에서 대조구보다 단백질 발현양이 증가한 것을 확인할 수 있었다.

• 대한방사성의약품학회지
• /
• 제7권2호
• /
• pp.105-111
• /
• 2021

⁸⁹Zr is a positron-emitting radioisotope, which has known as well-suited radioisotope for use in a monoclonal antibody-based imaging agent for immuno-PET. The purpose of this study was to quantitatively evaluate the diagnostic ability of general trastuzumab and thio-trastuzumab as HER2 positive receptors based on Df hexadentate iron chelator. Desferrioxamine-p-SCN (Df-Bz-NCS) and desferroixamine-maleimide (Df-Mal) were purchased from Macrocyclics (Dallas, TX, USA). The trastuzumab was purchased from Roche (Schweiz), and thio-trastuzumab was obtained from professor Hyo-Jeong Hong group (Kangwon National University). The radioisotope ⁸⁹Zr was produced by domestic purification system and KIRAMS using medical cyclotron (50 MeV, Scantronix). The conjugates of Df-trastuzumab and Df-thio-trastuzumab were prepared with Df-Bz-NCS and Df-Mal under basic aqueous solution (pH 8-9) at room temperature, respectively. The conjugates purified by PD-10 column were mixed with dried ⁸⁹Zr chloride. ⁸⁹Zr-labeled conjugates were purified and concentrated by Amicon ultra centrifugal filter. The preparation step and time of ⁸⁹Zr-labeled conjugates was shorted as 4 steps within 2 hours. ⁸⁹Zr-labeled conjugates showed the highly radiochemical purity of over 98%, and were very stable until 7 days by the analysis of radio-ITLC method. Each radio-labeled conjugates were also exhibited the highly stability in both PBS buffer and mouse serum. Immuno-PET imaging of ⁸⁹Zr-labeled conjugates in mice bearing gastric cancer xenograft tumors with HER2 expression showed high tumor uptake in the NCI-N87 HER2-expressing. However, ⁸⁹Zr-Df-Mal-thio-trastuzumab showed a relatively lower tumor-to-background ratio than ⁸⁹Zr-Df-Bz-trastuzumab, as well as whole-body distribution. In the results, ⁸⁹Zr-Df-Bz-trastuzumab was evaluated to have a relatively higher HER2 diagnostic ability than ⁸⁹Zr-Df-Mal-thio-trastuzumab.

• Nuclear Engineering and Technology
• /
• 제54권11호
• /
• pp.4102-4110
• /
• 2022

Aiming at high-power and long-pulse operation up to 1000 s, some improvements have been made for both 2.45 GHz and 4.6 GHz lower hybrid (LH) systems during the recent 5 years. At first, the guard limiters of the LH antennas with graphite tiles were upgraded to tungsten, the most promising material for plasma facing components in nuclear fusion devices. These new guard limiters can operate at a peak power density of 12.9 MW/m². Strong hot spots were usually observed on the old graphite limiters when 4.6 GHz system operated with power >2.0 MW [B. N. Wan et al., Nucl. Fusion 57 (2017) 102019], leading to a reduction of the maximum power capability. With the new limiters, 4.6 GHz LH system, the main current drive (CD) and electron heating tool for EAST, can be operated with power >2.5 MW routinely. Long-pulse operation up to 100 s with 4.6 GHz LH power of 2.4 MW was achieved in 2021 and the maximal temperature on the guard limiters measured by an infrared (IR) camera was about 540 ℃, much below the permissible value of tungsten material (~1200 ℃). A discharge with a duration of 1056 s was achieved and the 4.6 GHz LH energy injected into the plasma was up to 1.05 GJ. Secondly, the fully-active-multijunction (FAM) launcher of 2.45 GHz system was upgraded to a passive-active-multijunction (PAM), for which the density of optimum coupling was relatively low (below the cut-off value). Good coupling with reflection coefficient ~3% has been achieved with plasma-antenna distance up to 11 cm for the new PAM. Finally, in order to eliminate the effect of ion cyclotron range of frequencies (ICRF) wave on 4.6 GHz LH wave coupling, the location of the ICRF launcher was changed to a port that is located 157.5° toroidally from the 4.6 GHz LH system and is not magnetically connected.

• 대한수의학회지
• /
• 제41권4호
• /
• pp.571-578
• /
• 2001

방사선 피폭선량의 예측을 위한 방사선 민감 지표 모델 개발의 일환으로 apoptotic fragment assay법이 방사선에 피폭된 후 체내 피폭선량을 예측할 수 있는 지표로의 이용 가능성을 평가하기 위하여 코발트-60 감마선과 의료용 싸이크로트론 50MeV($p{\rightarrow}Be^+$) fast neutron 을 0.25Gy에서 1Gy의 선량을 마우스에 각각 전신 조사한 후 소장 음와세포내 apoptotic crypt cell의 수적 변화를 관찰하였다. 저선량 조사군에서 apoptotic crypt cell의 출현 빈도가 1Gy까지 급격하게 증가한 것으로 보아 방사선이 stem cell 지역에 있는 crypt cell의 형태학적 변화를 유발하는 것으로 나타났다. 이상의 결과는 아포토시스가 손상된 세포를 제거하므로 손상된 방사선 민감 표적 장기의 항상성 유지에 중요한 역할을 하는 것으로 판단되었다. Apoptotic fragments의 발생빈도에 대한 선량-반응 곡선에 있어서 음와세포는 중성자조사군이 $y=0.18+(9.728{\pm}0.887)D+(-4.727{\pm}1.033)D^2$ ($r^2=0.984$)으로, 반면에 감마선조사군은 $y=0.18+(5.125{\pm}0.601)D+(-2.652{\pm}0.7000)D^2$ ($r^2=0.970$)의 식을 얻었다. 이와 같이 중성자조사군과 감마선조사군은 공히 linear quadratic model 로 관찰되었다. apoptotic fragments 의 발생빈도와 조사 선량간에 유의한 효과가 있는 것으로 확인되었다. 이상의 결과에서 조사선량의 증가에 비례하여 방사선 민감 세포의apoptotic fragments 가 수적으로 증가하였으며, 고준위 방사선과 저준위 방사선은 선량 반응 관계식과 시간 경과에 따른 영향이 매우 유사하였으며, 마우스 음와세포의 apoptosis 유도에 대한 중성자선의 방사선 생물학적 효과비(RBE)는 2.072이였다. 그리고 모든 방사선조사군에서 방사선피폭 후 4시간과 6시간에 apoptosis 유도가 가장 많았으며, 음와세포의 형태학적 소견은 정상 대조군에서 관찰되지 않는 전형적인 apoptotic fragments 가 나타났다. 따라서 음와 세포에서의 아포토시스 유도는 방사선 피폭으로 발생된 세포 손상의 생물학적 영향 평가검색, 방사선 방호제의 민감도 검사, 방사성 동위원소의 체내 오염에 대한 체내 피폭선량 예측의 지표 및 방사선 민감 표적장기의 손상정도 파악에 이용 가능할 것임. Apoptotic fragment assay 법은 0.25Gy에서 1Gy 까지의 선량에서 간편하고 빠르며 재현성이 있는 지표로서 방사선 민감 표적 장기의 선량 반응 평가와 방사선 피폭후 조기 피폭선량 예측을 위한 방사선 생물학적 선량측정법의 좋은 지표로 사용할 수 있을 것으로 사료됨.

• 대한핵의학회지
• /
• 제18권2호
• /
• pp.17-23
• /
• 1984

For nearly a century it has been known that chemical activity accompanies mental activity, but only recently has it been possible to begin to examine its exact nature. Positron-emitting radioactive tracers have made it possible to study the chemistry of the human mind in health and disease, using chiefly cyclotron-produced radionuclides, carbon-11, fluorine-18 and oxygen-15. It is now well established that measurable increases in regional cerebral blood flow, glucose and oxygen metabolism accompany the mental functions of perception, cognition, emotion and motion. On May 25, 1983 the first imaging of a neuroreceptor in the human brain was accomplished with carbon-11 methyl spiperone, a ligand that binds preferentially to dopamine-2 receptors, 80% of which are located in the caudate nucleus and putamen. Quantitative imaging of serotonin-2, opiate, benzodiazapine and muscarinic cholinergic receptors has subsequently been accomplished. In studies of normal men and women, it has been found that dopamine and serotonin receptor activity decreases dramatically with age, such a decrease being more pronounced in men than in women and greater in the case of dopamine receptors than serotonin-2 receptors. Preliminary studies in patients with neuropsychiatric disorders suggests that dopamine-2 receptor activity is diminished in the caudate nucleus of patients with Huntington's disease. Positron tomography permits quantitative assay of picomolar quantities of neuro-receptors within the living human brain. Studies of patients with Parkinson's disease, Alzheimer's disease, depression, anxiety, schizophrenia, acute and chronic pain states and drug addiction are now in progress. The growth of any scientific field is based on a paradigm or set of ideas that the community of scientists accepts. The unifying principle of nuclear medicine is the tracer principle applied to the study of human disease. Nineteen hundred and sixty-three was a landmark year in which technetium-99m and the Anger camera combined to move the field from its latent stage into a second stage characterized by exponential growth within the framework of the paradigm. The third stage, characterized by gradually declining growth, began in 1973. Faced with competing advances, such as computed tomography and ultrasonography, proponents and participants in the field of nuclear medicine began to search for greener pastures or to pursue narrow sub-specialties. Research became characterized by refinements of existing techniques. In 1983 nuclear medicine experienced what could be a profound change. A new paradigm was born when it was demonstrated that, despite their extremely low chemical concentrations, in the picomolar range, it was possible to image and quantify the distribution of receptors in the human body. Thus, nuclear medicine was able to move beyond physiology into biochemistry and pharmacology. Fundamental to the science of pharmacology is the concept that many drugs and endogenous substances, such as neurotransmitters, react with specific macromolecules that mediate their pharmacologic actions. Such receptors are usually identified in the study of excised tissues, cells or cell membranes, or in autoradiographic studies in animals. The first imaging and quantification of a neuroreceptor in a living human being was performed on May 25, 1983 and reported in the September 23, 1983 issue of SCIENCE. The study involved the development and use of carbon-11 N-methyl spiperone (NMSP), a drug with a high affinity for dopamine receptors. Since then, studies of dopamine and serotonin receptors have been carried out in over 100 normal persons or patients with various neuropsychiatric disorders. Exactly one year later, the first imaging of opitate receptors in a living human being was performed [1].

• 대한핵의학회지
• /
• 제33권3호
• /
• pp.327-336
• /
• 1999

목적: 이 연구의 목적은 3D FDG-PET 뇌영상의 정량적 정확도와 임상적 유용성을 연구하는 것이다. 대상 및 방법: 24명의 환자에게 약 370 MBq의 FDG를 주사하고 섭취되기까지 30분을 대기한 후 GE $Advance^{TM}$ PET을 사용하여 30분간의 2D 영상과 10분간의 3D 영상을 얻었다. 백질, 회백질, 병변, 정상조직의 관심영역 분석을 통하여 영상대비와 FDG 섭취비를 구하여 비교하였다. 3D PET의 효율을 최대화하기 위하여 투과스캔을 사용한 경우와 사용하지 않은 경우의 감쇠보정 효과를 비교하였다. 결과 3D 영상의 영상대비는 2D 영상이 1 일 때 산란보정을 실행한 경우 회백질 대 백질에서 $0.95{\pm}0.12$, 정상 대 병변에서 $0.96{\pm}0.05$이었다. 2D 영상의 FDG 섭취비가 1일 때 3D 영상의 FDG 섭취비는 산란보정을 실행한 경우 $1.02{\pm}0.08$이었다. 3D 영상은 영상대비, 분해능, 영상 잡음에 대한 순위 척도평가에서 각각 81%, 83%, 81%에 해당되는 등급을 받아 선호도가 우수하였다. 3D 영상에서 계산감쇠보정 방법은 측정감쇠보정 방법에 필적하는 결과를 얻었다. 결론: 산란보정과 계산감쇠보정을 실시한 3D 영상은 일반적인 2D 영상과 비교하여 정량적으로 정확한 결과를 나타냈으며 정성적으로 유용하였다. 3D 영상은 일상 임상환경에 충분히 적용할 수 있으며 환자 스캔 시간을 단축하고 방사능 피폭량을 감소시키는 장점이 있었다.

• 대한핵의학회지
• /
• 제36권1호
• /
• pp.1-7
• /
• 2002

Positron Emission Tomography (PET) is a nuclear medicine imaging modality that consists of systemic administration to a subject of a radiopharmaceutical labeled with a positron-emitting radionuclide. Following administration, its distribution in the organ or structure under study can be assessed as a function of time and space by (1) defecting the annihilation radiation resulting from the interaction of the positrons with matter, and (2) reconstructing the distribution of the radioactivity from a series of that used in computed tomography (CT). The nuclides most generally exhibit chemical properties that render them particularly desirable in physiological studies. The radionuclides most widely used in PET are F-18, C-11, O-15 and N-13. Regarding to the number of the current PET Centers worldwide (based on ICP data), more than 300 PET Centers were in operation in 2000. The use of PET technology grew rapidly compared to that in 1992 and 1996, particularly in the USA, which demonstrates a three-fold rise in PET installations. In 2001, 194 PET Centers were operating in the USA. In 1994, two clinical and research-oriented PET Centers at Seoul National University Hospital and Samsung Medical Center, was established as the first dedicated PET and Cyclotron machines in Korea, followed by two more PET facilities at the Korea Cancer Center Hospital, Ajou Medical Center, Yonsei University Medical Center, National Cancer Center and established their PET Center. Catholic Medical School and Pusan National University Hospital have finalized a plan to install PET machine in 2002, which results in total of nine PET Centers in Korea. Considering annual trends of PET application in four major PET centers in Korea in Asan Medical Center recent six years (from 1995 to 2000), a total of 11,564 patients have been studied every year and the number of PET studies has shown steep growth year upon year. We had 1,020 PET patients in 1995. This number increased to 1,196, 1,756, 2,379, 3,015 and 4,414 in 1996,1997,1998,1999 and 2000, respectively. The application in cardiac disorders is minimal, and among various neuropsychiatric diseases, patients with epilepsy or dementia can benefit from PET studios. Recently, we investigated brain mapping and neuroreceptor works. PET is not a key application for evaluation of the cardiac patients in Korea because of the relatively low incidence of cardiac disease and less costly procedures such as SPECT can now be performed. The changes in the application of PET studios indicate that, initially, brain PET occupied almost 60% in 1995, followed by a gradual decrease in brain application. However, overall PET use in the diagnosis and management of patients with cancer was up to 63% in 2000. The current medicare coverage policy in the USA is very important because reimbursement policy is critical for the promotion of PET. In May 1995, the Health Care Financing Administration (HCFA) began covering the PET perfusion study using Rubidium-82, evaluation of a solitary pulmonary nodule and pathologically proven non-small cell lung cancer. As of July 1999, Medicare's coverage policy expanded to include additional indications: evaluation of recurrent colorectal cancer with a rising CEA level, staging of lymphoma and detection of recurrent or metastatic melanoma. In December of 2001, National Coverage decided to expand Medicare reimbursement for broad use in 6 cancers: lung, colorecctal, lymphoma, melanoma, head and neck, and esophageal cancers; for determining revascularization in heart diseases; and for identifying epilepsy patients. In addition, PET coverage is expected to further expand to diseases affecting women, such as breast, ovarian, uterine and vaginal cancers as well as diseases like prostate cancer and Alzheimer's disease.

• 대한핵의학회지
• /
• 제32권1호
• /
• pp.50-60
• /
• 1998

국내에서 제조한 I-123-IPPA의 안정성 및 동물체내 분포와 대사, 그리고 SPECT 영상 분석 방법을 연구하였다. I-123-IPPA의 안정성을 보기 위하여 사람 및 랫트와 마우스 혈청과 반응시킨 후 1 시간 동안 관찰한 결과 I-123이 유리되지 않았다. 마우스에 I-123-IPPA 투여 후 장기를 적출 하여 본 체내 분포는 심장의 단위무게당 섭취는 5분에 14.5%ID/g 기관당 섭취는 1.9%ID/organ 이었다. 주사량 대비 심장 섭취율은 주사 60분에 처음의 1/4-1/6로 줄었다. 심근대 혈액 비와 심근 대 폐와 심근 대 간 섭취 비는 I-123-IPPA 투여 후 처음 5분까지 증가하다가 이후 계속 감소하였다. 랫트에 I-123-IPPA를 투여한 후 혈액과 소변 크로마토그라피에는 I-123-IPPA가 15-20분 후에 혈액이나 소변 중에 I-123-IPPA는 거의 남지 않고 여러 중간 물질이 되었다. 심근경색 실험견에 경색을 만들기 전과 후에 시행한 심근 동적 SPECT에서 정상 심근은 I-123-IPPA가 섭취되었다가 제거되는 모습으로, 경색 부위는 I-123-IPPA의 섭취 결손으로 보였다. 심근의 I-123-IPPA SPECT에 보이는 결손은 Tc-99m-MIBI SPECT와 F-18-FDG PET에 보이는 결손과 비슷하였다. 이상의 결과는 원자력병원 싸이클로트론 응용 연구실에서 제조한 I-123-IPPA가 심근 질환의 대사를 평가하는데 사용할 수 있음을 나타낸다.

• 한국표면공학회:학술대회논문집
• /
• 한국표면공학회 2009년도 춘계학술대회 논문집
• /
• pp.111-112
• /
• 2009

Diamond-like carbon (DLC) is a convenient term to indicate the compositions of the various forms of amorphous carbon (a-C), tetrahedral amorphous carbon (ta-C), hydrogenated amorphous carbon and tetrahedral amorphous carbon (a-C:H and ta-C:H). The a-C film with disordered graphitic ordering, such as soot, chars, glassy carbon, and evaporated a-C, is shown in the lower left hand corner. If the fraction of sp3 bonding reaches a high degree, such an a-C is denoted as tetrahedral amorphous carbon (ta-C), in order to distinguish it from sp2 a-C [2]. Two hydrocarbon polymers, that is, polyethylene (CH2)n and polyacetylene (CH)n, define the limits of the triangle in the right hand corner beyond which interconnecting C-C networks do not form, and only strait-chain molecules are formed. The DLC films, i.e. a-C, ta-C, a-C:H and ta-C:H, have some extreme properties similar to diamond, such as hardness, elastic modulus and chemical inertness. These films are great advantages for many applications. One of the most important applications of the carbon-based films is the coating for magnetic hard disk recording. The second successful application is wear protective and antireflective films for IR windows. The third application is wear protection of bearings and sliding friction parts. The fourth is precision gages for the automotive industry. Recently, exciting ongoing study [1] tries to deposit a carbon-based protective film on engine parts (e.g. engine cylinders and pistons) taking into account not only low friction and wear, but also self lubricating properties. Reduction of the oil consumption is expected. Currently, for an additional application field, the carbon-based films are extensively studied as excellent candidates for biocompatible films on biomedical implants. The carbon-based films consist of carbon, hydrogen and nitrogen, which are biologically harmless as well as the main elements of human body. Some in vitro and limited in vivo studies on the biological effects of carbon-based films have been studied [$2{\sim}5$].The carbon-based films have great potentials in many fields. However, a few technological issues for carbon-based film are still needed to be studied to improve the applicability. Aisenberg and Chabot [3] firstly prepared an amorphous carbon film on substrates remained at room temperature using a beam of carbon ions produced using argon plasma. Spencer et al. [4] had subsequently developed this field. Many deposition techniques for DLC films have been developed to increase the fraction of sp3 bonding in the films. The a-C films have been prepared by a variety of deposition methods such as ion plating, DC or RF sputtering, RF or DC plasma enhanced chemical vapor deposition (PECVD), electron cyclotron resonance chemical vapor deposition (ECR-CVD), ion implantation, ablation, pulsed laser deposition and cathodic arc deposition, from a variety of carbon target or gaseous sources materials [5]. Sputtering is the most common deposition method for a-C film. Deposited films by these plasma methods, such as plasma enhanced chemical vapor deposition (PECVD) [6], are ranged into the interior of the triangle. Application fields of DLC films investigated from papers. Many papers purposed to apply for tribology due to the carbon-based films of low friction and wear resistance. Figure 1 shows the percentage of DLC research interest for application field. The biggest portion is tribology field. It is occupied 57%. Second, biomedical field hold 14%. Nowadays, biomedical field is took notice in many countries and significantly increased the research papers. DLC films actually applied to many industries in 2005 as shown figure 2. The most applied fields are mold and machinery industries. It took over 50%. The automobile industry is more and more increase application parts. In the near future, automobile industry is expected a big market for DLC coating. Figure 1 Research interests of carbon-based filmsFigure 2 Demand ratio of DLC coating for industry in 2005. In this presentation, I will introduce a trend of carbon-based coating research and applications.

• 핵의학기술
• /
• 제15권2호
• /
• pp.3-12
• /
• 2011

본 연구는 방사성동위원소의 의학적 이용도가 증가함에 따라 의료기관 핵의학과 방사선관계종사자의 직무별 방사선 이용에 대한 개인 방사선피폭선량의 실태를 파악하여, 방사선 위험에 대해 경각심을 고취시키고, 방사선 관계종사자들에게 안전관리와 합리적인 피폭선량 관리에 도움을 주고자 분석하였다. 2010년 1월 1일부터 2010년 12월 31일까지 의료기관에서 근무하는 방사선종사자로 분류되어 개인 방사선피폭선량 측정을 정기적, 연속적으로 1년간 조사 관리된 540명의 종사자를 대상으로 부서별, 선량영역구간별, 근무기간별, 직무별 관련업무를 파악하여 심부선량에 대하여 연간평균피폭선량을 각각 분석하였다. 분석법으로는 빈도분석과 ANOVA를 시행하였다. 의료기관 방사선종사자의 부서별 연간피폭선량은 핵의학과 4.57 mSv로 가장 높았으며, 심장혈관중재술실 2.09 mSv, 마취통증의학과 1.42 mSv, 영상의학과 1.10 mSv, 구강악안면 방사선과 0.59 mSv, 방사선종양학과 0.50 mSv 순으로 높게 나타났다. 선량영역별 분포는 핵의학과, 심장혈관중재술실에서 5.01~19.05 mSv의 높은 선량영역분포를 보였으며, 부서별 방사선사의 연간피폭선량은 핵의학과 7.14 mSv로 가장 높은 피폭선량을 보이고 있으며, 심장혈관중재술실 1.46 mSv로 높았고, 영상의학과 0.97 mSv, 구강악안면방사선과 0.66 mSv, 방사선종양학과 0.54 mSv 순으로 나타났다. 세부업무에 따른 직무별 연간평균피폭선량은 싸이크로트론 관련 합성 업무 17.47 mSv로 가장 높은 피폭선량을 보였으며, Gamma camera 영상실 7.24 mSv, PET/CT 영상실 업무가 7.60 mSv로 높게 나타났고, 인터벤션 2.04 mSv, 심혈관중재술실 1.46 mSv, 일반촬영 1.21 mSv, Primart 치료실 0.90 mSv, 구강악안면방사선과 일반촬영 0.66 mSv 순으로 나타났다. 근무기간별, 선량영역별에 따른 연간평균피폭선량은 구강악안면방사선과에서는 10~14년 종사자가 1.01~3.00 mSv로 높은 평균선량을 보였고, 방사선종양학과는 모든 근무기간에 따라 0.00~1.00 mSv 의 낮은 선량영역구간에서 분포를 보였으며, 심혈관중재술실은 10~14년, 15~19년 근무에 따라 각각 1.01~3.00 mSv 선량영역구간에서 분포하였으며, 영상의학과에서는 1~4년, 5~9년 종사자가 각각 1.01~8.00 mSv의 가장 높은 선량영역구간에서 분포를 보였고, 핵의학과에서는 1~4년, 5~9년 종사자가 각각 3.01~19.05 mSv 의 가장 높은 선량영역구간에서 분포를 보였으며, 10~14년, 15~19년 종사자에서도 각각 3.01~15.00 mSv의 높은 선량영역구간에서 분포를 보였다. 이와 같은 결과로 볼 때 의료기관에서 근무하는 방사선관계종사자의 대부분이 현재의 방사선 안전관리가 실효성 있게 이루어지고 있었으며, 직무특성에 따라 많은 차이가 있는 것을 알게 되었다. 그러나 방사선 피폭을 최소화시키는 노력이 필요하며, 이를 위해서 체계적 교육과 합리적인 피폭량 관리를 위한 체계가 필요하다고 사료된다.